Pyxis Oncology, Inc. is a preclinical biotechnology firm based in Cambridge, Massachusetts, focused on advancing innovative therapies for cancer treatment through the development of antibody-drug conjugates (ADCs) and monoclonal antibodies (mAbs). With a commitment to harnessing the power of targeted therapies, Pyxis aims to enhance the efficacy and safety profiles of oncology treatments, addressing unmet medical needs in the oncology landscape. The company's cutting-edge research and strategic partnerships position it for potential breakthroughs in cancer therapy.
Click "Analyze" to generate stock analysis
PYXS Price Trend and Signals
PYXS Option Volumes & Open Interests (aggregated)
PYXS Put Call Ratios and IV (aggregated)
PYXS Financials
2025-10-23Somewhat Bearishmacd_signal
Dead cross above zero detected.
2025-10-09Neutralvolume_signal
Abnormal volume detected compared to 5-day moving average.
2025-10-09Neutralvolume_signal
Abnormal volume detected compared to 10-day moving average.
2025-10-09Neutralvolume_signal
Abnormal volume detected compared to 20-day moving average.
2025-10-09Neutralvolume_signal
Abnormal volume detected compared to 3 mon moving average.
2025-10-09Somewhat Bullishprice_signal
Half-yearly high detected.
2025-10-09Bullishprice_signal
Large price change detected: 31.62%.
2025-10-09Neutraloption_volume_signal
Abnormal option volume detected compared to 5-day moving average.
2025-10-09Neutraloption_volume_signal
Abnormal option volume detected compared to 10-day moving average.
2025-10-09Neutraloption_volume_signal
Abnormal option volume detected compared to 20-day moving average.
2025-10-09Neutraloption_volume_signal
Abnormal option volume detected compared to 3 mon moving average.